Wright Medical Grp Inc: (NASD: WMGI)

$23.59

-0.07 (-0.30%)

Volume 191,745

May 23 01:38 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		23.46 - 23.86
	
		52wk Low - High
		18.11 - 25.08
	
		Previous Close
		23.66
	
		Avg. Volume
		353,319
	
		Industry
		MED PRODUCTS
	
		Market Cap
		1.11 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.80
	
		PE (Forward)
		0.00
	
		Current Year Est.
		-0.28
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		184 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/21/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            NA
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            -0.28
                        
                            Current Quarter Estimate
                            -0.13
                        
                            Most Accurate Estimate
                            -0.13
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-07-2013
                        
                            EPS Last Year
                            0.05
                        
                            Expected Earnings Growth
                            11.38%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Wright Medical Group, Inc. is a global orthopaedic device company specializing in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials. Reconstructive joint devices are used to replace knee, hip and other joints that have deteriorated through disease or injury. Bio-orthopaedic materials are used to replace damaged or diseased bone and to stimulate natural bone growth.   
Full WMGI Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
WMGI Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	-0.13	-0.11	-0.28	0.01
Number of Estimates	8	8	10	7
Low Estimate	-0.15	-0.12	-0.30	-0.15
High Estimate	-0.08	-0.08	-0.25	NA
Year Ago EPS	0.08	-0.02	0.23	-0.28
EPS Growth	-262.50%	-431.25%	-220.43%	102.58%

More WMGI Estimates

Average Earnings Estimates for WMGI

EPS Growth for WMGI

Industry Analysis

Name	Symbol	Previous Close
WRIGHT MEDICAL	WMGI	23.66
ATRICURE INC	ATRC	9.14
CONCEPTUS INC	CPTS	30.94
INVIVO THERAPT	NVIV	2.90
TRANS1 INC	TSON	1.80
ABAXIS INC	ABAX	43.51
ADVAXIS INC	ADXS	0.04
BAXTER INTL	BAX	72.30
BIO-RAD LABS -A	BIO	115.39
BIOLIFE SOL INC	BLFS	0.37

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Wright Medical Stays Neutral

May 22, 2013

WMGI Loss Narrower than Est.

May 01, 2013

Wright Medical Concludes Take over

Mar 06, 2013

Reiterate Wright Medical at Neutral

Mar 04, 2013

WMGI Beats Est, Reports Profit

Feb 25, 2013

Wright to Combine with BioMimetic

Nov 23, 2012

Secondary Offering by MAKO

Nov 14, 2012

WMGI Turns to Loss in 3Q; Down Y-Y

Nov 06, 2012

More WMGI Zacks Commentary

Financials

EPS TTM	0.05
Sales	484
Net Income	9
Price/Earnings	473.20
Price/Book	1.58
Price/Cash Flow	16.56
Price/Sales	2.32

More WMGI Financials

News

Short-term Underperformance Detected in Shares of ABIOMED in the Health Care Equipment Industry (ABMD, EW, DXCM, WMGI, BCR) - Financial News Network Online - News Corner

May 22, 2013

Wright Medical Group, Inc. to Participate in Jefferies 2013 Global Healthcare Conference - Businesswire

May 22, 2013

Earnings Look Back: Wright Medical Is Up 5.1% Since Reporting Quarterly Results 2 Weeks Ago (WMGI) - Comtex Smartrend(R)

May 20, 2013

Wright Medical Earnings In Retrospect: Up 5.1% in the Last 18 Days (WMGI) - Financial News Network Online - Earnings Lookback

May 18, 2013

Wright Medical: The Winning Streak Continues (WMGI) - Financial News Netwfork Online - 52-Week High-Lows

May 15, 2013

Shares of Wright Medical Have Risen Above Previous 52-Week High - Financial News Netwfork Online - 52-Week High-Lows

May 14, 2013

Stocks Hitting 52-Week Highs - Benzinga

May 14, 2013

Wright Medical Group, Inc. Appoints Douglas G. Watson to Board of Directors - Businesswire

May 14, 2013

See All News Stories on WMGI

Broker Recommendations

Current ABR	2.08
ABR (Last Week)	2.08
# of recs in ABR	13
Average Target Price	25.09
Industry Rank by ABR	184 out of 265
Rank in Industry	5 out of 73

More WMGI Broker Recommendations

Day Low - High	23.46 - 23.86
52wk Low - High	18.11 - 25.08
Previous Close	23.66
Avg. Volume	353,319
Industry	MED PRODUCTS
Market Cap	1.11 B
Div - Yield	0.00 - 0.00
Beta	0.80
PE (Forward)	0.00
Current Year Est.	-0.28
Quarterly Earnings ESP	0.00%

PE (Forward)	NA
PEG Ratio	NA
Current Year Est.	-0.28
Current Quarter Estimate	-0.13
Most Accurate Estimate	-0.13
Earnings ESP	0.00%
Next Earnings Report Date	08-07-2013
EPS Last Year	0.05
Expected Earnings Growth	11.38%

Username: Password:

Remember me [?]

Wright Medical Grp Inc: (NASD: WMGI)

$23.59

-0.07 (-0.30%)

Volume 191,745

May 23 01:38 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED PRODUCTS

Zacks Commentary

Financials

News

Broker Recommendations